Prelude Therapeutics Inc (PRLD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRLD Annual Balance Sheets →
This page allows investors to track Prelude Therapeutics Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent26.33
Marketable Securities, Current SH125.43
Cash & Short-term Investments151.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.14
Total Current Assets154.90
Equipment/Property/Plant Net4.40
Other Assets, Noncurrent30.07
Restricted Cash3.24
Operating Lease Right Of Use Asset26.78
Total Assets189.36
Liabilities
Accounts Payable, Current AC2.03
Accrued Liabilities, Current AC7.98
Other Liabilities, Current2.78
Deferred Revenue, Current DE25.25
Total Current Liabilities38.04
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent17.59
Operating Lease Liability Current2.76
Total Liabilities55.63
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock841.32
Retained Earnings / Accumulated Deficit-707.37
Accumulated Other Comprehensive Income-0.23
Other Equity-0.23
Common Stockholder's Equity133.73
Total Stockholder's Equity133.73
Liabilities & Stockholder's Equity189.36
4 historic quarters locked

Sign in to unlock the full Prelude Therapeutics Inc balance sheet history.

About Prelude Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-343475

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.